$2.490
-0.020 (-0.80%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EDIT Prediction & Forecast by Similar Chart Analysis
Alphio's EDIT stock price prediction model matches the current Editas Medicine Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.39 (-0.51%). The 1-week path is $2.43 (+1.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Editas Medicine Inc Stock?
Editas Medicine Inc is a good buy right now due to its recent clinical trial approval for EDIT-401, which has shown promising results in reducing bad cholesterol by approximately 90%. The current price is $2.35, significantly below the analyst price target of $6, indicating a potential upside of 114%. Additionally, the stock has a gross margin of 100%, showing strong profitability potential. However, the main risk is the company's high debt-to-equity ratio of 1240.40%, which could impact financial stability if not managed carefully.
EDIT stock price ended at $2.49 on Thursday, after losing -0.80%
Editas Medicine Inc (EDIT) last closed at $2.4, losing -3.61%. These facts feed the 1-day and 1-week EDIT price prediction above.
Analyst Consensus
Editas Medicine Inc (EDIT): 4 buy, 4 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Editas Medicine Inc (EDIT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EDIT, ranked by similarity.
Seasonality analysis for EDIT
Historically the probability of a positive October return for EDIT is 63.49%. June offers the highest probability of a positive month at 68.33%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EDIT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.46 | $3.63 | $3.73 | +51.34% |
| Nov 2026 | $2.76 | $2.92 | $3.42 | +21.72% |
| Dec 2026 | $2.59 | $2.96 | $3.62 | +23.40% |
In 2026, Editas Medicine Inc (EDIT) is projected to range from $2.59 to $3.73.
Editas Medicine Inc 2026 monthly forecast
In Oct 2026, Editas Medicine Inc is projected to average $3.63, with a low of $3.46 and high of $3.73.
In Nov 2026, Editas Medicine Inc is projected to average $2.92, with a low of $2.76 and high of $3.42.
In Dec 2026, Editas Medicine Inc is projected to average $2.96, with a low of $2.59 and high of $3.62.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.